SCHEMBL3095670

SCHEMBL3095670

COC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CC(=O)N(CCN(C)C)Cc1sccc1-3

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.42
MMP12 P39900 1/20 0.42
NR1I2 O75469 5/20 0.38
SCN9A Q15858 2/20 0.36
KCNH2 Q12809 5/20 0.36
CYP3A4 P08684 2/20 0.35
SCN5A Q14524 2/20 0.35
CSNK2A1 P68400 1/20 0.35
RXRA P19793 1/20 0.35
ALDH1A1 P00352 2/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3080352 0.87 PRKCA (0.48) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL3088693 0.87 PRKCA (0.42) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL3093091 0.85 KCNH2 (0.44) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL3092990 0.85 PRKCA (0.41) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL3089899 0.83 PRKCA (0.41) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL14253294 0.81 PRKCA (0.48) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL3074886 0.80 PRKCA (0.46) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL3095015 0.78 PRKCA (0.40) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL894723 0.78 PRKCA (0.48) PRKCAMMP12NR1I2SCN9AKCNH2
SCHEMBL3079784 0.78 PRKCA (0.51) PRKCAMMP12NR1I2SCN9AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795247-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-14 US disclosed
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHEDI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IRMB) (IT) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents IDO1, ZC3HAV1, IDO2 PRKCA 3874/4885MMP12 3319/4885NR1I2 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.